THE MECHANICAL STUDY OF RECOMBINANT HUMAN ERYTHROPOIETIN ON A RAT MODEL OF NEUROPATHIC PAIN

JIA Hong-Bin,LIU Jian,LI Wei-Yan,XU Jian-Guo,JIN Yi
DOI: https://doi.org/10.3969/j.issn.1006-9852.2013.03.009
2013-01-01
Abstract:Objective: To investigate the effect of rhEPO administrated intraperitoneally before or after nerve injury on the behavioral manifestation and the activation of glial cell in spinal cord using a rat model of neuropathic pain induced by L5 nerve transection.Methods: The thirty male Sprague-Dawley(SD) rats were randomly assigned into three groups: sham-operation with saline,L5 spinal nerve transection with saline and L5 spinal nerve transection with rhEPO(5000 U/kg).rhEPO or saline was given intraperitoneally 1 day before surgery and continued daily to day 7 post-transection.The hind paw mechanical withdrawal threshold(MWT) and thermal withdrawal latency(TWL) of all animals were measured on day 7 after operation with von Frey hairs and Hargreaves tests,respectively.The transcription of mRNA of glial cell surface markers such as CD11b and GFAP was semi-quantitatively evaluated using real-time PCR assay.Results: Administration of rhEPO resulted in attenuation in mechanical and thermal hyperalgesia.Furthermore,rhEPO could markedly inhibit the level of mRNA expression of CD11b and GFAP in the spine cord(P < 0.05).Conclusion: We found the potential preventive value of rhEPO in the treatment of neuropathic pain,which correlated with the decreased spinal cord mRNA expression of CD11b and GFAP.
What problem does this paper attempt to address?